Hvis incidenshyppigheden for simvastatin var mindre end eller sammenlignelig med placebo i disse undersøgelser, og der var spontane rapporter om rimeligt sammenlignelige årsagssammenhænge, kategoriseret disse bivirkninger som ” sjældne ”.
If the incidence rates on simvastatin were less than or similar to that of placebo in these trials, and there were similar reasonably causally related spontaneous report events, these adverse events are categorized as “ rare”.